Stock info Resmed Inc | Filter  Basic-Info

Resmed Inc

Resmed Inc is mostly active in the pharmaceutical sector. Over the past 10 years the global pharmaceutical companies gained around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The past year was a profitable year for Resmed Inc investors

Over the last 12 months (from December 2015 till December 2016), that were profitable period for the investors in Resmed Inc, the stock gained around 14 percent. Over the period 2011-2016 the stock rose a massive 154,81 percent. Resmed Inc's revenues between 2011 and 2015 were quite stable and moved between 1,37 billion dollars and 1,68 billion dollars. Resmed Inc's net results between 2011 and 2015 were quite unstable and moved between 226,99 million dollars and 352,89 million dollars.

Over the past 5 years the American company paid out dividends. On average the Resmed Inc stock yielded a delivered a dividend yield of around 2,8 percent over the past 5 years.

Resmed Inc' balance mostly financed with equity

At the end of 2015 the pharmaceutical company's balance sheet was worth 2,18 billion dollars. The total debt was around 596,95 million dollars. This is 27,33 percent of the total balance sheet. Last year the pharmaceutical company's price/earnings-ratio (PE) was around 22. So the investors valued the stock at 22 times 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

The pharmaceutical company's market capitalization (the number of shares outstanding times the market value) equaled around 7,35 billion dollars. At the end of 2015 the American company had around 140,47 million stocks listed on the stock exchange(s).

All Resmed Inc's annual reports can be found here. More information about Resmed Inc can be found it's website. .